The metabolic syndrome represents a specific cluster of phenotypes that increase the risk for coronary heart disease and type-2 diabetes mellitus. 1, 2, 3, 4 Owing to ...
The Telmisartan and Losartan Cardiac Evaluation Trial, a multicenter, prospective, randomized, open-labeled, blinded-endpoint trial, was designed to compare the effects of two angiotensin II receptor ...
Chika E. Okereke, MD; Franz H. Messerli, MD, Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA A total of 57% of ...
Nephropathy and retinopathy remain important complications of type 1 diabetes. It is unclear whether their progression is slowed by early administration of drugs that block the renin–angiotensin ...
Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About ...
Bethesda, MD The FDA Cardiovascular and Renal Drugs Advisory Committee has voted unanimously to grant AstraZeneca LP the right to claim superiority of once-a-day dosing with candesartan cilexetil ...
Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries. We evaluated the renoprotective effects of dual blockade of the renin−angiotensin−aldosterone system by ...
Thousands of bottles of blood-pressure medicine are being recalled after the Food and Drug Administration said trace amounts of potential carcinogens were found to be in the medicine. Camber ...
(NBC) — Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback